OSSFF (Embla Medical hf) Price-to-Tangible-Book: (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSSFF Embla Medical hf OSSFF
87 GF Score
Price $4.55
GF Value $5.26
Valuation Modestly Undervalued
View Full Analysis

What is Embla Medical hf Price-to-Tangible-Book?

As of today (2026-08-28), Embla Medical hf's share price is $4.55. Embla Medical hf's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was $-0.01. Hence, Embla Medical hf's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Embla Medical hf's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Embla Medical hf's highest Price to Tangible Book Ratio was 239.26. The lowest was 39.74. And the median was 91.15.

OSSFF's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.66
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Embla Medical hf's share price is $4.55. Embla Medical hf's Book Value per Sharefor the quarter that ended in Jun. 2026 was $2.16. Hence, Embla Medical hf's P/B Ratio of today is 2.10.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Embla Medical hf Price-to-Tangible-Book Related Terms


Embla Medical hf Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Price-to-Tangible-Book Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Embla Medical hf Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSSFF vs ABT, SYK, MDT: Price-to-Tangible-Book Comparison

For the Medical Devices subindustry, Embla Medical hf's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf Price-to-Tangible-Book vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Price-to-Tangible-Book falls into.


OSSFF
87GF Score
Embla Medical hf OSSFF
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Price-to-Tangible-Book Calculation

Embla Medical hf's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=4.55/-0.014
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.55 is trading 13.5% below its estimated GF Value™ of $5.26. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for OSSFF:

  • Price-to-Tangible-Book:
  • GF Value™: $5.26 vs. price of $4.55 (13.5% below fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
87GF Score

Get the complete analysis for OSSFF

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.55
Price
$5.26
GF Value